S41598-021-83773-1.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Melioidosis: an Emerging Infectious Disease
Review Article www.jpgmonline.com Melioidosis: An emerging infectious disease Raja NS, Ahmed MZ,* Singh NN** Department of Medical ABSTRACT Microbiology, University of Malaya Medical Center, Kuala Lumpur, Infectious diseases account for a third of all the deaths in the developing world. Achievements in understanding Malaysia, *St. the basic microbiology, pathogenesis, host defenses and expanded epidemiology of infectious diseases have Bartholomew’s Hospital, resulted in better management and reduced mortality. However, an emerging infectious disease, melioidosis, West Smithfield, London, is becoming endemic in the tropical regions of the world and is spreading to non-endemic areas. This article UK and **School of highlights the current understanding of melioidosis including advances in diagnosis, treatment and prevention. Biosciences, Cardiff Better understanding of melioidosis is essential, as it is life-threatening and if untreated, patients can succumb University, Cardiff, UK to it. Our sources include a literature review, information from international consensus meetings on melioidosis Correspondence: and ongoing discussions within the medical and scientific community. N. S. Raja, E-mail: [email protected] Received : 21-2-2005 Review completed : 20-3-2005 Accepted : 30-5-2005 PubMed ID : 16006713 KEY WORDS: Melioidosis, Burkholderia pseudomallei, Infection J Postgrad Med 2005;51:140-5 he name melioidosis [also known as Whitmore dis- in returning travellers to Europe from endemic areas.[14] The T ease] is taken from the Greek word ‘melis’ meaning geographic area of the prevalence of the organism is bound to distemper of asses and ‘eidos’ meaning resembles glanders. increase as the awareness increases. Melioidosis is a zoonotic disease caused by Pseudomonas pseudomallei [now known as Burkholderia pseudomallei], a B. -
Genomes of the T4-Related Bacteriophages As Windows on Microbial Genome Evolution
Petrov et al. Virology Journal 2010, 7:292 http://www.virologyj.com/content/7/1/292 REVIEW Open Access Genomes of the T4-related bacteriophages as windows on microbial genome evolution Vasiliy M Petrov1, Swarnamala Ratnayaka1, James M Nolan2, Eric S Miller3, Jim D Karam1* Abstract The T4-related bacteriophages are a group of bacterial viruses that share morphological similarities and genetic homologies with the well-studied Escherichia coli phage T4, but that diverge from T4 and each other by a number of genetically determined characteristics including the bacterial hosts they infect, the sizes of their linear double- stranded (ds) DNA genomes and the predicted compositions of their proteomes. The genomes of about 40 of these phages have been sequenced and annotated over the last several years and are compared here in the con- text of the factors that have determined their diversity and the diversity of other microbial genomes in evolution. The genomes of the T4 relatives analyzed so far range in size between ~160,000 and ~250,000 base pairs (bp) and are mosaics of one another, consisting of clusters of homology between them that are interspersed with segments that vary considerably in genetic composition between the different phage lineages. Based on the known biologi- cal and biochemical properties of phage T4 and the proteins encoded by the T4 genome, the T4 relatives reviewed here are predicted to share a genetic core, or “Core Genome” that determines the structural design of their dsDNA chromosomes, their distinctive morphology and the process of their assembly into infectious agents (phage morphogenesis). -
Avoidance of Mechanisms of Innate Immune Response by Neisseria Gonorrhoeae
ADVANCEMENTS OF MICROBIOLOGY – POSTĘPY MIKROBIOLOGII 2019, 58, 4, 367–373 DOI: 10.21307/PM–2019.58.4.367 AVOIDANCE OF MECHANISMS OF INNATE IMMUNE RESPONSE BY NEISSERIA GONORRHOEAE Jagoda Płaczkiewicz* Department of Virology, Institute of Microbiology, Faculty of Biology, University of Warsaw Submitted in July, accepted in October 2019 Abstract: Neisseria gonorrhoeae (gonococcus) is a Gram-negative bacteria and an etiological agent of the sexually transmitted disease – gonorrhea. N. gonorrhoeae possesses many mechanism to evade the innate immune response of the human host. Most are related to serum resistance and avoidance of complement killing. However the clinical symptoms of gonorrhea are correlated with a significant pres- ence of neutrophils, whose response is also insufficient and modulated by gonococci. 1. Introduction. 2. Adherence ability. 3. Serum resistance and complement system. 4. Neutrophils. 4.1. Phagocytosis. 4.1.1. Oxygen- dependent intracellular killing. 4.1.2. Oxygen-independent intracellular killing. 4.2. Neutrophil extracellular traps. 4.3. Degranulation. 4.4. Apoptosis. 5. Summary UNIKANIE MECHANIZMÓW WRODZONEJ ODPOWIEDZI IMMUNOLOGICZNEJ PRZEZ NEISSERIA GONORRHOEAE Streszczenie: Neisseria gonorrhoeae (gonokok) to Gram-ujemna dwoinka będąca czynnikiem etiologicznym choroby przenoszonej drogą płciową – rzeżączki. N. gonorrhoeae posiada liczne mechanizmy umożliwiające jej unikanie wrodzonej odpowiedzi immunologicznej gospodarza. Większość z nich związana jest ze zdolnością gonokoków do manipulowania układem dopełniacza gospodarza oraz odpor- nością tej bakterii na surowicę. Jednakże symptomy infekcji N. gonorrhoeae wynikają między innymi z obecności licznych neutrofili, których aktywność jest modulowana przez gonokoki. 1. Wprowadzenie. 2. Zdolność adherencji. 3. Surowica i układ dopełniacza. 4. Neutrofile. 4.1. Fagocytoza. 4.1.1. Wewnątrzkomórkowe zabijanie zależne od tlenu. 4.1.2. -
Laboratory Manual for Diagnosis of Sexually Transmitted And
Department of AIDS Control LaborLaboraattororyy ManualManual fforor DiagnosisDiagnosis ofof SeSexxuallyually TTrransmitansmittteded andand RRepreproductivoductivee TTrractact InInffectionsections FOREWORD Sexually Transmitted Infections (STIs) and Reproductive Tract Infections (RTIs) are diseases of major global concern. About 6% of Indian population is reported to be having STIs. In addition to having high levels of morbidity, they also facilitate transmission of HIV infection. Thus control of STIs goes hand in hand with control of HIV/AIDS. Countrywide strengthening of laboratories by helping them to adopt uniform standardized protocols is very important not only for case detection and treatment, but also to have reliable epidemiological information which will help in evaluation and monitoring of control efforts. It is also essential to have good referral services between primary level of health facilities and higher levels. This manual aims to bring in standard testing practices among laboratories that serve health facilities involved in managing STIs and RTIs. While generic procedures such as staining, microscopy and culture have been dealt with in detail, procedures that employ specific manufacturer defined kits have been left to the laboratories to follow the respective protocols. An introduction to quality system essentials and quality control principles has also been included in the manual to sensitize the readers on the importance of quality assurance and quality management system, which is very much the need of the hour. Manual of Operating Procedures for Diagnosis of STIs/RTIs i PREFACE Sexually Transmitted Infections (STIs) are the most common infectious diseases worldwide, with over 350 million new cases occurring each year, and have far-reaching health, social, and economic consequences. -
Detection of Tick-Borne Pathogens of the Genera Rickettsia, Anaplasma and Francisella in Ixodes Ricinus Ticks in Pomerania (Poland)
pathogens Article Detection of Tick-Borne Pathogens of the Genera Rickettsia, Anaplasma and Francisella in Ixodes ricinus Ticks in Pomerania (Poland) Lucyna Kirczuk 1 , Mariusz Piotrowski 2 and Anna Rymaszewska 2,* 1 Department of Hydrobiology, Faculty of Biology, Institute of Biology, University of Szczecin, Felczaka 3c Street, 71-412 Szczecin, Poland; [email protected] 2 Department of Genetics and Genomics, Faculty of Biology, Institute of Biology, University of Szczecin, Felczaka 3c Street, 71-412 Szczecin, Poland; [email protected] * Correspondence: [email protected] Abstract: Tick-borne pathogens are an important medical and veterinary issue worldwide. Environ- mental monitoring in relation to not only climate change but also globalization is currently essential. The present study aimed to detect tick-borne pathogens of the genera Anaplasma, Rickettsia and Francisella in Ixodes ricinus ticks collected from the natural environment, i.e., recreational areas and pastures used for livestock grazing. A total of 1619 specimens of I. ricinus were collected, including ticks of all life stages (adults, nymphs and larvae). The study was performed using the PCR technique. Diagnostic gene fragments msp2 for Anaplasma, gltA for Rickettsia and tul4 for Francisella were ampli- fied. No Francisella spp. DNA was detected in I. ricinus. DNA of A. phagocytophilum was detected in 0.54% of ticks and Rickettsia spp. in 3.69%. Nucleotide sequence analysis revealed that only one species of Rickettsia, R. helvetica, was present in the studied tick population. The present results are a Citation: Kirczuk, L.; Piotrowski, M.; part of a large-scale analysis aimed at monitoring the level of tick infestation in Northwest Poland. -
Antigen Detection Assay for the Diagnosis of Melioidosis
PI: Title: Antigen Detection assay for the Diagnosis of Melioidosis Received: 12/05/2013 FOA: PA10-124 Council: 05/2014 Competition ID: ADOBE-FORMS-B1 FOA Title: NIAID ADVANCED TECHNOLOGY STTR (NIAID-AT-STTR [R41/R42]) 2 R42 AI102482-03 Dual: Accession Number: 3650491 IPF: 3966401 Organization: INBIOS INTERNATIONAL, INC. Former Number: Department: IRG/SRG: ZRG1 IDM-V (12)B AIDS: N Expedited: N Subtotal Direct Costs Animals: N New Investigator: N (excludes consortium F&A) Humans: Y Early Stage Investigator: N Year 3: Clinical Trial: N Year 4: Current HS Code: E4 Year 5: HESC: N Senior/Key Personnel: Organization: Role Category: Always follow your funding opportunity's instructions for application format. Although this application demonstrates good grantsmanship, time has passed since the grantee applied. The sample may not reflect the latest format or rules. NIAID posts new samples periodically: https://www.niaid.nih.gov/grants-contracts/sample-applications The text of the application is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited. Note on Section 508 conformance and accessibility: We have reformatted these samples to improve accessibility for people with disabilities and users of assistive technology. If you have trouble accessing the content, please contact the NIAID Office of Knowledge and Educational Resources at [email protected]. Additions for Review Accepted Publication Accepted manuscript news Post-submission supplemental material. Information about manuscript accepted for publication. OMB Number: 4040-0001 Expiration Date: 06/30/2011 APPLICATION FOR FEDERAL ASSISTANCE 3. DATE RECEIVED BY STATE State Application Identifier SF 424 (R&R) 1. -
Non-Coding Rnas of the Q Fever Agent, Coxiella Burnetii
University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2015 Non-coding RNAs of the Q fever agent, Coxiella burnetii Indu Ramesh Warrier The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Warrier, Indu Ramesh, "Non-coding RNAs of the Q fever agent, Coxiella burnetii" (2015). Graduate Student Theses, Dissertations, & Professional Papers. 4620. https://scholarworks.umt.edu/etd/4620 This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. NON-CODING RNAS OF THE Q FEVER AGENT, COXIELLA BURNETII By INDU RAMESH WARRIER M.Sc (Med), Kasturba Medical College, Manipal, India, 2010 Dissertation presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy Cellular, Molecular and Microbial Biology The University of Montana Missoula, MT August, 2015 Approved by: Sandy Ross, Dean of The Graduate School Graduate School Michael F. Minnick, Chair Division of Biological Sciences Stephen J. Lodmell Division of Biological Sciences Scott D. Samuels Division of Biological Sciences Scott Miller Division of Biological Sciences Keith Parker Department of Biomedical and Pharmaceutical Sciences Warrier, Indu, PhD, Summer 2015 Cellular, Molecular and Microbial Biology Non-coding RNAs of the Q fever agent, Coxiella burnetii Chairperson: Michael F. Minnick Coxiella burnetii is an obligate intracellular bacterial pathogen that undergoes a biphasic developmental cycle, alternating between a small cell variant (SCV) and a large cell variant (LCV). -
Francisella Tularensis Subspecies Holarctica and Tularemia in Germany
microorganisms Review Francisella tularensis Subspecies holarctica and Tularemia in Germany 1, 2, 3 1 1 Sandra Appelt y, Mirko Faber y , Kristin Köppen , Daniela Jacob , Roland Grunow and Klaus Heuner 3,* 1 Centre for Biological Threats and Special Pathogens (ZBS 2), Robert Koch Institute, 13353 Berlin, Germany; [email protected] (S.A.); [email protected] (D.J.); [email protected] (R.G.) 2 Gastrointestinal Infections, Zoonoses and Tropical Infections (Division 35), Department for Infectious Disease Epidemiology, Robert Koch Institute, 13353 Berlin, Germany; [email protected] 3 Cellular Interactions of Bacterial Pathogens, ZBS 2, Robert Koch Institute, 13353 Berlin, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-301-8754-2226 These authors contributed equally to this work. y Received: 27 August 2020; Accepted: 18 September 2020; Published: 22 September 2020 Abstract: Tularemia is a zoonotic disease caused by Francisella tularensis a small, pleomorphic, facultative intracellular bacterium. In Europe, infections in animals and humans are caused mainly by Francisella tularensis subspecies holarctica. Humans can be exposed to the pathogen directly and indirectly through contact with sick animals, carcasses, mosquitoes and ticks, environmental sources such as contaminated water or soil, and food. So far, F. tularensis subsp. holarctica is the only Francisella species known to cause tularemia in Germany. On the basis of surveillance data, outbreak investigations, and literature, we review herein the epidemiological situation—noteworthy clinical cases next to genetic diversity of F. tularensis subsp. holarctica strains isolated from patients. In the last 15 years, the yearly number of notified cases of tularemia has increased steadily in Germany, suggesting that the disease is re-emerging. -
Dr. Martha Clokie Department of Infection, Immunity and Inflammation, University of Leicester, UK
Graduate Schools Infection Immunity and Cancer, UniGe & UniL: CUS Biology & Medicine, CMU Seminars in Microbiology Monday, 8th December, 2014 Salle de séminaire 7172, CMU 11:00 – 12:00 Dr. Martha Clokie Department of Infection, Immunity and Inflammation, University of Leicester, UK The ecology, evolution and applications of Clostridium difficile bacteriophages Clostridia are Gram positive, anaerobic, sporulating bacteria of which some are important human pathogens. Clostridium difficile is present in the gut and is known to cause antibiotic treatment associated diarrhea. Bacteria have a core genome that is complemented by many genes that contribute to strain specific behavior and possibility to adapt to different environments. Some of these genes, which may encode virulence factors in pathogenic bacteria, are encoded by bacteriophages. The group of Martha Clokie has recently shown that a Clostridium phage encodes an agr-type quorum sensing system (QS), in which a secreted peptide represents the signaling molecule. It is suggested that the phage encoded agr system, which is missing the transcriptional activator AgrA, was taken from a bacterium and is transferred horizontally between Clostridia strains, thereby influencing the behavior of the lysogenic bacteria, though the interaction with resident agr quorum sensing systems in Clostridium. Hargreaves et al., Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen. MBio. 2014;5:e01045-13. Hargreaves et al., Bacteriophage behavioral ecology: How phages alter their bacterial host's habits. Bacteriophage. 2014 8;4:e29866. Hargreaves et al. What does the talking?: quorum sensing signalling genes discovered in a bacteriophage genome. -
Pathogenic Bacteria and Clinical Significance Raphael Eisenhofer Inje University College of Medicine, Korea
Journal of Microbiology and Immunology AbstractEditoial Pathogenic bacteria and clinical significance Raphael Eisenhofer Inje University College of Medicine, Korea Pathogenic bacteria are bacteria that can cause disease. cystic fibrosis. Examples of these opportunistic pathogens This article deals with human pathogenic bacteria. Al- include Pseudomonas aeruginosa, Burkholderia cenoce- though most bacteria are harmless or often beneficial, pacia, and Mycobacterium avium. Intracellular: Obligate some are pathogenic, with the number of species esti- intracellular parasites (e.g. Chlamydophila, Ehrlichia, mated as fewer than a hundred that are seen to cause Rickettsia) have the ability to only grow and replicate in- infectious diseases in humans. By contrast, several thou- side other cells. Even these intracellular infections may sand species exist in the human digestive system. One of be asymptomatic, requiring an incubation period. An ex- the bacterial diseases with the highest disease burden is ample of this is Rickettsia which causes typhus. Another tuberculosis, caused by Mycobacterium tuberculosis bac- causes Rocky Mountain spotted fever. Chlamydia is a phy- teria, which kills about 2 million people a year, mostly lum of intracellular parasites. These pathogens can cause in sub-Saharan Africa. Pathogenic bacteria contribute to pneumonia or urinary tract infection and may be involved other globally important diseases, such as pneumonia, in coronary heart disease. Other groups of intracellular which can be caused by bacteria such as Streptococcus bacterial pathogens include Salmonella, Neisseria, Brucel- and Pseudomonas, and foodborne illnesses, which can la, Mycobacterium, Nocardia, Listeria, Francisella, Legio- be caused by bacteria such as Shigella, Campylobacter, nella, and Yersinia pestis. These can exist intracellularly, and Salmonella. -
Resveratrol Is Cidal to Both Classes of Haemophilus Ducreyi
International Journal of Antimicrobial Agents 41 (2013) 477–479 Contents lists available at SciVerse ScienceDirect International Journal of Antimicrobial Agents jou rnal homepage: http://www.elsevier.com/locate/ijantimicag Short communication Resveratrol is cidal to both classes of Haemophilus ducreyi ∗ Erin M. Nawrocki, Hillary W. Bedell, Tricia L. Humphreys Allegheny College Department of Biology, 520N. Main St., Meadville, PA 16335, USA a r t i c l e i n f o a b s t r a c t Article history: Resveratrol, a polyphenolic phytoalexin, is produced by plants in response to infection and has antibacte- Received 13 November 2012 rial activity. Haemophilus ducreyi is a Gram-negative bacterium that is the causative agent of the sexually Accepted 7 February 2013 transmitted disease chancroid. This study employed minimum cidal concentration (MCC) assays to eval- uate the potential of resveratrol as a microbicide against H. ducreyi. Five class I and four class II strains Keywords: of H. ducreyi tested had MCCs ≤500 g/mL. Resveratrol was also tested against Lactobacillus spp., part Haemophilus ducreyi of the natural vaginal flora. Representative strains of Lactobacillus were co-cultured with H. ducreyi and Chancroid 500 g/mL resveratrol; in all cases, Lactobacillus was recovered in greater numbers than H. ducreyi. These Lactobacillus Resveratrol results show that resveratrol is not only bacteriostatic but is bactericidal to H. ducreyi, confirming the Microbicide compound’s potential for use as a topical microbicide to prevent chancroid. © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved. 1. Introduction [9]. The recommended treatment regimens for chancroid rely on azithromycin, ceftriaxone, ciprofloxacin or erythromycin, but H. -
Translating Phage-Based Applications Into Clinically and Commercially
SPEAKERS TO INCLUDE: Steffanie Strathdee Carl Merril Scott Stibitz & Tom Patterson CSO and Founder Microbiologist, Center for University of Adaptive Phage Biologics Evaluation and California San Diego Therapeutics Research FDA 29-30TH JANUARY 2019 | WASHINGTON D.C, USA Translating phage-based applications into clinically and commercially viable therapeutics Martha Clokie Biswajit Biswas Joe Campbell Professor of Chief, Division of Research Resources Microbiology Bacteriophage Science, Project Officer University of Biological Defense NIH (NIAID) Regulatory guidance to achieve clinical data from Cara Fiore, FDA Leicester Research Directorate US Naval Medical Research Center Strategies to access the market via the veterinary, personalized medicine and traditional pharmaceutical routes INSTITUTIONS PRESENT INCLUDE: Insights into investment drivers for phage therapy from NIH and Merck Facts on how to manufacture GMP phage Applications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics www.phage-futures.com | +44 (0)20 3696 2920 | [email protected] WELCOME The Phage Futures Congress has the potential to act as a catalyst to further With antimicrobial resistance an ongoing worldwide issue, there is now a renewed interest cooperative and collaborative efforts in phage therapy as an alternative to antibiotics. There has been uncertainty as to whether to develop alternate Phage based approaches to phage therapy can be a commercially viable and FDA/EMA approved product. However, the the antibiotic